TAKHZYRO lanadelumab 300mg/2mL solution for injection vial

Takeda Pharmaceuticals Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 2b6d920606c925ec
Product Name: TAKHZYRO lanadelumab 300mg/2mL solution for injection vial
Artg Id: 302300
Artg Name: TAKHZYRO lanadelumab (rch) 300mg/2mL solution for injection vial
Sponsor: Takeda Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/takeda-pharmaceuticals-australia-pty-ltd
Artg Date: 2019-01-30
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-PI-01119-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

2b6d920606c925ec

Type

Standard